These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 10933916)
1. Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6. Allen JM; Halbert CL; Miller AD Mol Ther; 2000 Jan; 1(1):88-95. PubMed ID: 10933916 [TBL] [Abstract][Full Text] [Related]
2. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines. Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356 [TBL] [Abstract][Full Text] [Related]
3. Enhanced preparation of adeno-associated viral vectors by using high hydrostatic pressure to selectively inactivate helper adenovirus. Leonard JN; Ferstl P; Delgado A; Schaffer DV Biotechnol Bioeng; 2007 Aug; 97(5):1170-9. PubMed ID: 17252611 [TBL] [Abstract][Full Text] [Related]
5. Development of packaging cell lines for generation of adeno-associated virus vectors by lentiviral gene transfer of trans-complementary components. Nakamura S; Nakamura R; Shibata K; Kobayashi M; Sahara N; Shigeno K; Shinjo K; Naito K; Ohnishi K; Kasahara N; Iwaki Y Eur J Haematol; 2004 Oct; 73(4):285-94. PubMed ID: 15347316 [TBL] [Abstract][Full Text] [Related]
6. Adeno-associated viral vectors for gene transfer and gene therapy. Büeler H Biol Chem; 1999 Jun; 380(6):613-22. PubMed ID: 10430026 [TBL] [Abstract][Full Text] [Related]
7. Increased titer of recombinant AAV vectors by gene transfer with adenovirus coupled to DNA-polylysine complexes. Mamounas M; Leavitt M; Yu M; Wong-Staal F Gene Ther; 1995 Aug; 2(6):429-32. PubMed ID: 7584119 [TBL] [Abstract][Full Text] [Related]
8. Generation of recombinant adeno-associated virus vectors by a complete adenovirus-mediated approach. Zhang X; Li CY Mol Ther; 2001 May; 3(5 Pt 1):787-92. PubMed ID: 11356083 [TBL] [Abstract][Full Text] [Related]
9. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus. Liu XL; Clark KR; Johnson PR Gene Ther; 1999 Feb; 6(2):293-9. PubMed ID: 10435114 [TBL] [Abstract][Full Text] [Related]
10. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus. Cheshenko N; Krougliak N; Eisensmith RC; Krougliak VA Gene Ther; 2001 Jun; 8(11):846-54. PubMed ID: 11423932 [TBL] [Abstract][Full Text] [Related]
11. Efficient expression of the vascular endothelial growth factor gene in vitro and in vivo, using an adeno-associated virus vector. Byun J; Heard JM; Huh JE; Park SJ; Jung EA; Jeong JO; Gwon HC; Kim DK J Mol Cell Cardiol; 2001 Feb; 33(2):295-305. PubMed ID: 11162134 [TBL] [Abstract][Full Text] [Related]
12. Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phosphatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo. Zhong L; Chen L; Li Y; Qing K; Weigel-Kelley KA; Chan RJ; Yoder MC; Srivastava A Mol Ther; 2004 Nov; 10(5):950-7. PubMed ID: 15509512 [TBL] [Abstract][Full Text] [Related]
13. An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction. Flotte TR; Barraza-Ortiz X; Solow R; Afione SA; Carter BJ; Guggino WB Gene Ther; 1995 Jan; 2(1):29-37. PubMed ID: 7712331 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of adenovirus cytotoxicity, replication, and E2a gene expression by adeno-associated virus. Jing XJ; Kalman-Maltese V; Cao X; Yang Q; Trempe JP Virology; 2001 Dec; 291(1):140-51. PubMed ID: 11878883 [TBL] [Abstract][Full Text] [Related]
15. A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors. Clark KR; Voulgaropoulou F; Johnson PR Gene Ther; 1996 Dec; 3(12):1124-32. PubMed ID: 8986439 [TBL] [Abstract][Full Text] [Related]
16. Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus. Zhang HG; Wang YM; Xie JF; Liang X; Hsu HC; Zhang X; Douglas J; Curiel DT; Mountz JD Gene Ther; 2001 May; 8(9):704-12. PubMed ID: 11406765 [TBL] [Abstract][Full Text] [Related]
17. AAV vectors for hemophilia B gene therapy. Chao H; Walsh CE Mt Sinai J Med; 2004 Oct; 71(5):305-13. PubMed ID: 15543431 [TBL] [Abstract][Full Text] [Related]
18. Self-amplification system for recombinant adeno-associated virus production. Urabe M; Shimazaki K; Saga Y; Okada T; Kume A; Tobita K; Ozawa K Biochem Biophys Res Commun; 2000 Sep; 276(2):559-63. PubMed ID: 11027513 [TBL] [Abstract][Full Text] [Related]
19. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector. Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924 [TBL] [Abstract][Full Text] [Related]
20. Production of helper-dependent adenovirus vector relies on helper virus structure and complementing. Zhou HS; Zhao T; Rao XM; Beaudet AL J Gene Med; 2002; 4(5):498-509. PubMed ID: 12221643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]